- Home
- CRVS vs TEN Comparison
CRVS vs TEN Comparison
Compare CRVS & TEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- TEN
- Stock Information
- Founded
- CRVS 2014
- TEN 1993
- Country
- CRVS United States
- TEN Greece
- Employees
- CRVS N/A
- TEN N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- TEN
- Sector
- CRVS Health Care
- TEN
- Exchange
- CRVS Nasdaq
- TEN NYSE
- Market Cap
- CRVS 516.0M
- TEN 531.7M
- IPO Year
- CRVS 2016
- TEN N/A
- Fundamental
- Price
- CRVS $4.99
- TEN $16.15
- Analyst Decision
- CRVS Buy
- TEN Buy
- Analyst Count
- CRVS 4
- TEN 2
- Target Price
- CRVS $12.83
- TEN $31.00
- AVG Volume (30 Days)
- CRVS 1.6M
- TEN 471.2K
- Earning Date
- CRVS 11-12-2024
- TEN 02-15-2025
- Dividend Yield
- CRVS N/A
- TEN 11.15%
- EPS Growth
- CRVS N/A
- TEN N/A
- EPS
- CRVS N/A
- TEN 5.46
- Revenue
- CRVS N/A
- TEN $836,042,000.00
- Revenue This Year
- CRVS N/A
- TEN N/A
- Revenue Next Year
- CRVS N/A
- TEN $11.66
- P/E Ratio
- CRVS N/A
- TEN $2.95
- Revenue Growth
- CRVS N/A
- TEN N/A
- 52 Week Low
- CRVS $1.30
- TEN $15.88
- 52 Week High
- CRVS $10.00
- TEN $31.48
- Technical
- Relative Strength Index (RSI)
- CRVS 28.00
- TEN 23.03
- Support Level
- CRVS $3.77
- TEN $15.88
- Resistance Level
- CRVS $7.44
- TEN $16.99
- Average True Range (ATR)
- CRVS 0.60
- TEN 0.64
- MACD
- CRVS -0.41
- TEN -0.08
- Stochastic Oscillator
- CRVS 25.85
- TEN 8.23
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers, and autoimmune diseases. The company's primary product candidate is Soquelitinib (CPI-818), an oral, small-molecule drug that selectively inhibits ITK (interleukin-2-inducible T cell kinase). The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About TEN TSAKOS ENERGY NAVIGATION
Tsakos Energy Navigation Ltd is a seaborne transportation service provider for crude oil and petroleum products. The company's carriers cater to national and international independent oil companies and refiners. It generates revenue through charter contracts with its clients, which include time, bareboat, and voyage charters, contracts of affreightment, and pool arrangements.